Connect with us

Health

Gene Therapy Shows Early Promise as Angelman Syndrome Treatment | Newsroom – UNC Health and UNC School of Medicine

Led by Ben Philpot, PhD, and Matt Judson, PhD, the new therapy was generally well-tolerated and prevented key signs of the condition…

Published

on

Article feature image

Led by Ben Philpot, PhD, and Matt Judson, PhD, the new therapy was generally well-tolerated and prevented key signs of the condition in animal models.
Ben Philpot, PhD
CHAPEL HILL, NC Scientists at the UNC School of Medicine have reported in the journal…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending